Confusion sparked by the setting up of a new committee for drug approvals has led to a slide in the number of new medicines getting cleared even as millions of Indians struggle with diabetes and heart failures remain a major killer. The Drug Controller General of India (DCGI) has shed its role as the sole approver of new drugs in the country after a new committee, set up by the health...
More »SEARCH RESULT
Banking on goodwill-Prince Frederick
The Rajasthan Youth Association Metro's food bank provides a meal a day to over 200 institutions across Chennai. Prince Frederick meets the people behind the 20-year initiative In its 2010 report, the United Nations' Food and Agriculture Organisation (FAO) states that just seven countries — India, China, the Democratic Republic of Congo, Bangladesh, Indonesia, Pakistan and Ethiopia — account for 65 per cent of the world's hungry.” The World Food Programme...
More »Fast Road to Disease
-Economic and Political Weekly India’s fast food products must be subject to mandatory labelling. The role of fast or “junk” food with its concentration of fats, sugar and salt in the rapid multiplication of non-communicable lifestyle diseases has been the subject of countless studies over the past few decades, especially in the west. (A classic book from the United States with a title that says it all is Fast Food Nation.) Now, the...
More »India's patent ruling on cancer may open door for cheaper HIV drugs
-Reuters India's move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a precedent that could extend to other treatments, including modern HIV/AIDS drugs, in a major blow to global pharmaceutical firms, experts say. On Monday, the Indian Patent Office effectively ended Bayer's monopoly for its Nexavar drug and issued its first-ever compulsory license allowing local generic maker Natco Pharma to make and sell the drug...
More »Natco gets India’s first compulsory licence-CH Unnikrishnan
In a landmark decision, India’s intellectual property office on Monday allowed Hyderabad-based Natco Pharma Ltd to make and sell a copycat version of German drug maker Bayer AG’s patented cancer treatment Nexavar. It’s the first time that an Indian company has been granted the so-called compulsory licence to market a generic version of a patented drug. The drug, patented by Bayer in India in 2008, is used in the treatment of...
More »